Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 24 | 2025 | 476 | 4.490 |
Why?
|
| Interleukin-10 | 11 | 2023 | 185 | 3.290 |
Why?
|
| Neovascularization, Physiologic | 10 | 2025 | 204 | 2.250 |
Why?
|
| Hyaluronic Acid | 7 | 2021 | 108 | 1.880 |
Why?
|
| Lignin | 3 | 2025 | 19 | 1.860 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2025 | 147 | 1.790 |
Why?
|
| Cicatrix | 4 | 2023 | 127 | 1.690 |
Why?
|
| Fibroblasts | 8 | 2021 | 864 | 1.650 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2025 | 341 | 1.220 |
Why?
|
| Endothelial Progenitor Cells | 2 | 2022 | 11 | 1.210 |
Why?
|
| Skin | 6 | 2025 | 553 | 1.010 |
Why?
|
| Free Radical Scavengers | 1 | 2025 | 56 | 0.890 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 95 | 0.880 |
Why?
|
| Oxygen | 2 | 2025 | 552 | 0.860 |
Why?
|
| Gene Transfer Techniques | 5 | 2015 | 343 | 0.850 |
Why?
|
| Surgical Wound | 1 | 2022 | 21 | 0.740 |
Why?
|
| Wound Infection | 5 | 2022 | 53 | 0.730 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 518 | 0.730 |
Why?
|
| Hymecromone | 1 | 2021 | 10 | 0.720 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 27 | 0.720 |
Why?
|
| Nanofibers | 3 | 2025 | 14 | 0.680 |
Why?
|
| STAT3 Transcription Factor | 3 | 2022 | 233 | 0.680 |
Why?
|
| Antioxidants | 1 | 2023 | 336 | 0.650 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 211 | 0.650 |
Why?
|
| Mice | 26 | 2025 | 18486 | 0.630 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 4769 | 0.620 |
Why?
|
| Fetal Development | 3 | 2015 | 128 | 0.590 |
Why?
|
| Animals | 34 | 2025 | 34371 | 0.590 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2018 | 41 | 0.540 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 890 | 0.540 |
Why?
|
| NF-kappa B | 2 | 2018 | 449 | 0.500 |
Why?
|
| Hyperoxia | 1 | 2018 | 135 | 0.490 |
Why?
|
| Extracellular Matrix | 6 | 2020 | 231 | 0.470 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 7 | 0.470 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2015 | 20 | 0.470 |
Why?
|
| Signal Transduction | 3 | 2020 | 4683 | 0.460 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2018 | 214 | 0.460 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2015 | 323 | 0.460 |
Why?
|
| Dependovirus | 3 | 2013 | 157 | 0.460 |
Why?
|
| Pseudomonas Infections | 3 | 2022 | 117 | 0.450 |
Why?
|
| Cells, Cultured | 9 | 2025 | 2971 | 0.430 |
Why?
|
| Gene Expression | 1 | 2018 | 1501 | 0.420 |
Why?
|
| Cytomegalovirus | 1 | 2014 | 259 | 0.380 |
Why?
|
| Genetic Vectors | 2 | 2013 | 901 | 0.370 |
Why?
|
| Adenoviridae | 2 | 2015 | 582 | 0.370 |
Why?
|
| Viral Proteins | 1 | 2014 | 339 | 0.370 |
Why?
|
| Skin Ulcer | 1 | 2011 | 33 | 0.360 |
Why?
|
| Lung | 2 | 2018 | 1565 | 0.340 |
Why?
|
| Tissue Engineering | 2 | 2011 | 168 | 0.330 |
Why?
|
| Proteolysis | 1 | 2011 | 193 | 0.330 |
Why?
|
| Vagina | 2 | 2023 | 211 | 0.320 |
Why?
|
| Inflammation | 5 | 2025 | 1492 | 0.310 |
Why?
|
| Estrogens | 2 | 2023 | 436 | 0.300 |
Why?
|
| Wounds and Injuries | 2 | 2025 | 396 | 0.300 |
Why?
|
| Pulmonary Fibrosis | 2 | 2020 | 115 | 0.280 |
Why?
|
| Immune Tolerance | 2 | 2019 | 159 | 0.260 |
Why?
|
| Keratinocytes | 3 | 2016 | 74 | 0.250 |
Why?
|
| Cell Movement | 3 | 2015 | 881 | 0.250 |
Why?
|
| Endothelial Cells | 2 | 2025 | 536 | 0.240 |
Why?
|
| Hydrogels | 3 | 2025 | 101 | 0.230 |
Why?
|
| Endocardium | 1 | 2025 | 47 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 105 | 0.220 |
Why?
|
| Stress, Mechanical | 1 | 2025 | 179 | 0.220 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2022 | 174 | 0.210 |
Why?
|
| Kidney | 2 | 2020 | 1309 | 0.200 |
Why?
|
| Amnion | 1 | 2023 | 41 | 0.200 |
Why?
|
| Bandages | 2 | 2020 | 55 | 0.190 |
Why?
|
| Molecular Weight | 2 | 2020 | 297 | 0.190 |
Why?
|
| Biofilms | 2 | 2022 | 98 | 0.190 |
Why?
|
| Inovirus | 1 | 2022 | 2 | 0.190 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 83 | 0.190 |
Why?
|
| Propylene Glycol | 1 | 2021 | 8 | 0.180 |
Why?
|
| Administration, Cutaneous | 1 | 2021 | 68 | 0.180 |
Why?
|
| Dermis | 1 | 2021 | 28 | 0.180 |
Why?
|
| Collagen | 1 | 2023 | 289 | 0.180 |
Why?
|
| Gelatin | 1 | 2021 | 17 | 0.170 |
Why?
|
| Water | 1 | 2021 | 190 | 0.170 |
Why?
|
| Cytokines | 3 | 2025 | 1347 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 382 | 0.160 |
Why?
|
| Skin Care | 1 | 2020 | 14 | 0.160 |
Why?
|
| Financing, Organized | 1 | 2020 | 21 | 0.160 |
Why?
|
| Ethanol | 1 | 2021 | 164 | 0.160 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 31 | 0.160 |
Why?
|
| Debridement | 1 | 2020 | 90 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 792 | 0.160 |
Why?
|
| Writing | 1 | 2020 | 60 | 0.150 |
Why?
|
| Humans | 21 | 2025 | 131604 | 0.150 |
Why?
|
| Gastrostomy | 1 | 2020 | 88 | 0.150 |
Why?
|
| Pseudomonas Phages | 1 | 2019 | 10 | 0.150 |
Why?
|
| Bleomycin | 1 | 2019 | 111 | 0.150 |
Why?
|
| Genetic Therapy | 2 | 2015 | 726 | 0.140 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 4696 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 496 | 0.140 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 265 | 0.140 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 75 | 0.140 |
Why?
|
| Regeneration | 1 | 2020 | 231 | 0.140 |
Why?
|
| Phagocytosis | 1 | 2019 | 191 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 270 | 0.130 |
Why?
|
| Female | 12 | 2025 | 71145 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2020 | 2463 | 0.130 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 144 | 0.130 |
Why?
|
| Receptors, Notch | 1 | 2018 | 204 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 215 | 0.120 |
Why?
|
| Actins | 1 | 2018 | 317 | 0.120 |
Why?
|
| Macrophages | 1 | 2020 | 666 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 853 | 0.120 |
Why?
|
| Intestines | 1 | 2020 | 592 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 387 | 0.120 |
Why?
|
| Transduction, Genetic | 2 | 2013 | 279 | 0.110 |
Why?
|
| Male | 7 | 2025 | 65228 | 0.110 |
Why?
|
| Placental Insufficiency | 1 | 2015 | 14 | 0.110 |
Why?
|
| Myocardium | 1 | 2020 | 874 | 0.110 |
Why?
|
| Sex Factors | 1 | 2018 | 1346 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 62 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 824 | 0.100 |
Why?
|
| Allergens | 1 | 2017 | 356 | 0.100 |
Why?
|
| Capillaries | 2 | 2011 | 67 | 0.100 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 432 | 0.100 |
Why?
|
| Palate | 1 | 2013 | 19 | 0.100 |
Why?
|
| Algorithms | 1 | 2020 | 1686 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2015 | 769 | 0.100 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 48 | 0.100 |
Why?
|
| Skin Physiological Phenomena | 1 | 2013 | 16 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 259 | 0.100 |
Why?
|
| Saliva | 1 | 2013 | 137 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2015 | 3864 | 0.090 |
Why?
|
| Parvoviridae Infections | 1 | 2012 | 34 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 382 | 0.090 |
Why?
|
| Viral Tropism | 1 | 2012 | 48 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 261 | 0.090 |
Why?
|
| Fetal Therapies | 1 | 2012 | 85 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 676 | 0.090 |
Why?
|
| Ointments | 2 | 2021 | 13 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2011 | 123 | 0.080 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 471 | 0.080 |
Why?
|
| Trachea | 1 | 2012 | 209 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1356 | 0.080 |
Why?
|
| Placenta | 1 | 2015 | 529 | 0.080 |
Why?
|
| Child Development | 1 | 2013 | 272 | 0.080 |
Why?
|
| Swine | 2 | 2025 | 1188 | 0.080 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 267 | 0.080 |
Why?
|
| Biomarkers | 2 | 2015 | 3405 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1861 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2023 | 232 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3130 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2021 | 579 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8588 | 0.060 |
Why?
|
| Chorion | 1 | 2023 | 10 | 0.050 |
Why?
|
| Collagen Type VII | 1 | 2023 | 29 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2023 | 163 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 1610 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2017 | 567 | 0.050 |
Why?
|
| Pseudomonas | 1 | 2022 | 14 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 258 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2020 | 24 | 0.040 |
Why?
|
| Fetus | 2 | 2015 | 585 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 236 | 0.040 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2020 | 19 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 723 | 0.040 |
Why?
|
| Immunocompetence | 1 | 2019 | 31 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 245 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12964 | 0.040 |
Why?
|
| Abdomen | 1 | 2020 | 133 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 546 | 0.040 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2019 | 48 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 179 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 1101 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 460 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 366 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 420 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 136 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 414 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 434 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 50 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 56 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 65 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 643 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 362 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 244 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 307 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 1021 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2020 | 555 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 303 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 633 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 438 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 435 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2013 | 5 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 4 | 0.030 |
Why?
|
| Middle Aged | 1 | 2014 | 28883 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2151 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 54 | 0.020 |
Why?
|
| Pneumonia | 1 | 2017 | 344 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2013 | 80 | 0.020 |
Why?
|
| Adult | 1 | 2014 | 31702 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 1399 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 1169 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2011 | 28 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 80 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2363 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6494 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 261 | 0.020 |
Why?
|
| Pregnancy | 2 | 2015 | 7572 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 138 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17666 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 693 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 189 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2011 | 92 | 0.020 |
Why?
|
| Heart | 1 | 2015 | 675 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 3094 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2011 | 199 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 305 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1571 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2567 | 0.020 |
Why?
|
| Cell Communication | 1 | 2010 | 196 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1947 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 1221 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1002 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 20931 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1799 | 0.020 |
Why?
|
| Child | 2 | 2020 | 26250 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 21255 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6279 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 13305 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 15054 | 0.010 |
Why?
|